Kirk Habegger

About

Dr. Kirk Habegger is an Associate Professor at the University of Alabama at Birmingham, USA. His research primarily focuses on the metabolic effects of glucagon and insulin signaling, as well as the pharmacological interventions in metabolic diseases. Recent publications include investigations into targeted oral therapies for metabolic disorders, the interplay between insulin and glucagon receptor signaling, and the role of specific transcriptional co-regulators in metabolic processes.